0.00Open2.27Pre Close0 Volume75 Open Interest15.00Strike Price0.00Turnover64.31%IV2.04%PremiumNov 15, 2024Expiry Date2.01Intrinsic Value100Multiplier9DDays to Expiry0.27Extrinsic Value100Contract SizeAmericanOptions Type-0.9131Delta0.1272Gamma6.26Leverage Ratio-0.0099Theta-0.0024Rho-5.72Eff Leverage0.0032Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet